These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3629121)

  • 1. Morphological and functional abnormalities in platelets exposed in vitro to ioglicinic acid, a new ionic contrast medium.
    De Caterina M; Ruocco A; Violini M; Grassi R; Borgia G; Crowell J; Nappa S; di Minno G
    Ric Clin Lab; 1987; 17(2):143-7. PubMed ID: 3629121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
    Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
    Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media.
    Paajanen H; Kormano M; Uotila P
    Invest Radiol; 1984; 19(4):333-7. PubMed ID: 6434489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
    Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
    J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure.
    Gerrard JM; White JG; Rao GH
    Am J Pathol; 1974 Nov; 77(2):151-66. PubMed ID: 4447125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets from bleeding Simmental cattle mobilize calcium, phosphorylate myosin light chain and bind normal numbers of fibrinogen molecules but have abnormal cytoskeletal assembly and aggregation in response to ADP.
    Searcy GP; Frojmovic MM; McNicol A; Robertson C; Wong T; Gerrard JM
    Thromb Haemost; 1994 Feb; 71(2):240-6. PubMed ID: 8191406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of various contrast media on coagulation, fibrinolysis, and platelet function. An in vitro and in vivo study.
    Stormorken H; Skalpe IO; Testart MC
    Invest Radiol; 1986 Apr; 21(4):348-54. PubMed ID: 3700048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast agents used for excretory urography impair platelet function in human patients.
    Belleville J; Freyria AM; Pinet A; Cornillon B; Paul J; Clendinnen G; Eloy R
    Thromb Res; 1982 Nov; 28(4):533-44. PubMed ID: 7164034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast, coagulation, and fibrinolysis.
    Dawson P; Hewitt P; Mackie IJ; Machin SJ; Amin S; Bradshaw A
    Invest Radiol; 1986 Mar; 21(3):248-52. PubMed ID: 3957598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppressive effects of iodinated contrast media on human platelet aggregation].
    Tamura A; Ohata C; Hirakakiuchi Y; Sato T
    Yakugaku Zasshi; 1995 Mar; 115(3):250-5. PubMed ID: 7738783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of ioglicinic acid, a new ionic contrast medium.
    De Caterina M; Izzo M; Morelli L; Grimaldi E; Violini M; Grassi R
    Rays; 1986; 11(2):25-9. PubMed ID: 3602446
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonionic contrast medium: effects on blood coagulation and complement activation in vitro.
    Parvez Z; Moncada R
    Angiology; 1986 May; 37(5):358-64. PubMed ID: 3717700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
    Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
    Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
    Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
    Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes of platelets during the process of platelet aggregation in gray platelet syndrome.
    Mori K; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Sakai H
    Tohoku J Exp Med; 1986 Aug; 149(4):425-36. PubMed ID: 3775766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.